Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Pancreatic Ductal Adenocarcinoma
Related studies linked through entity extraction aliases.
Prevention of Upper Gastrointestinal Hemorrhage Using Albis® in the Patients of Locally Advanced Pancreatic Cancer Who Underwent Concurrent Chemoradiotherapy
- Status
- WITHDRAWN
- Phase
- PHASE4
Study of Tremelimumab in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial
- Status
- COMPLETED
- Phase
- PHASE2
Nab-pacliatxel Plus Gemcitabine in Korean Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy
- Status
- WITHDRAWN
- Phase
- N/A
A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)
- Status
- COMPLETED
- Phase
- PHASE1
Plasma Biomarkers P-DAC, V1
- Status
- TERMINATED
- Phase
- N/A
A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation
- Status
- COMPLETED
- Phase
- PHASE2
A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas
- Status
- UNKNOWN
- Phase
- N/A
A Biomarker Study to Identify Predictive Signatures of Response to LDE225 (Hedgehog Inhibitor) In Patients With Resectable Pancreatic Cancer
- Status
- WITHDRAWN
- Phase
- NA
Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial]
- Status
- UNKNOWN
- Phase
- NA
A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2